2-phenylethylyl-adenosine derivative - Moligand™ , Agonist of A 3 receptor, CAS No.P607137, Agonist of A 3 receptor

CAS: P607137 Cat. No.: P607137 PubChem CID: 44598833
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Storage
Room temperature
★
Taille
Allemagne (EU)
USA*
Prix
Qté
5mg
P607137-5mg
Sur commande · 8–12 semaines
868,52€
25mg
P607137-25mg
Sur commande · 8–12 semaines

1 488,09€

1 736,26€
Enregistrer 248,17 € (14.29%)
Enter a quantity for the sizes you want to add.

Spécifications

Spécifications et pureté
Moligand™
Conditions de stockage de stockage
Room temperature
Grade
Moligand™
Type d'action
AGONIST
Mécanisme d'action
Agonist of A 3 receptor
Noms et identifiants
SMILES
CNC(=O)[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(C#Cc1ccccc1)nc2NC
IUPAC Name
(2S,3S,4R,5R)-3,4-dihydroxy-N-methyl-5-[6-(methylamino)-2-(2-phenylethynyl)purin-9-yl]oxolane-2-carboxamide
InChIKey
PAFSPMXSTBOTSN-KSVNGYGVSA-N
InChI
1S/C20H20N6O4/c1-21-17-13-18(25-12(24-17)9-8-11-6-4-3-5-7-11)26(10-23-13)20-15(28)14(27)16(30-20)19(29)22-2/h3-7,10,14-16,20,27-28H,1-2H3,(H,22,29)(H,21,24,25)/t14-,15+,16-,20+/m0/s1
Isomères SMILES
CNC1=C2C(=NC(=N1)C#CC3=CC=CC=C3)N(C=N2)[C@H]4[C@@H]([C@@H]([C@H](O4)C(=O)NC)O)O
PubChem CID
44598833

Données avancées

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassNucleosides, nucleotides, and analogues
ClassePurine nucleosides
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentPurine nucleosides
Alternative Parents 6-alkylaminopurines  Glycosylamines  Secondary alkylarylamines  Aminopyrimidines and derivatives  N-substituted imidazoles  Imidolactams  Benzene and substituted derivatives  Oxolanes  Heteroaromatic compounds  Secondary carboxylic acid amides  Secondary alcohols  1,2-diols  Amino acids and derivatives  Oxacyclic compounds  Azacyclic compounds  Hydrocarbon derivatives  Carbonyl compounds  Organic oxides  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Purine nucleoside - Glycosyl compound - N-glycosyl compound - 6-alkylaminopurine - 6-aminopurine - Imidazopyrimidine - Purine - Aminopyrimidine - Secondary aliphatic/aromatic amine - Monocyclic benzene moiety - N-substituted imidazole - Imidolactam - Benzenoid - Pyrimidine - Azole - Heteroaromatic compound - Imidazole - Oxolane - Secondary alcohol - Secondary carboxylic acid amide - Amino acid or derivatives - 1,2-diol - Carboxamide group - Secondary amine - Organoheterocyclic compound - Azacycle - Oxacycle - Carboxylic acid derivative - Carbonyl group - Organic oxide - Organooxygen compound - Organic oxygen compound - Amine - Organonitrogen compound - Hydrocarbon derivative - Organic nitrogen compound - Alcohol - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as purine nucleosides. These are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety.
External Descriptors Not available
Structure 3D
Modèle de structure chimique interactif





Cibles associées (humaines)
ADORA3 Tchem Adenosine receptor A3 (4 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mécanismes d'action
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

No tested applications or recommended dilutions are provided for this product in the listing.

  • Item-specific: Not specified for this item; refer to CoA/Spec Sheet.

  • General guidance for small-molecule ligands in screening (non-item-specific):

    • Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM; vortex and sonicate if needed.
    • Working concentrations: Typical primary screens span 0.1–50 μM, depending on assay sensitivity and solubility. Maintain ≤0.5–1% v/v DMSO in final wells.
    • Controls: Include vehicle controls and, when available, reference ligands. Use counter-screens to flag assay interference (fluorescence quenchers, aggregators, redox cyclers).
    • Data quality: Assess Z′ factor, S/B ratio, and replicate variability; confirm hits in orthogonal assays.

These are general best practices and not validated, item-specific protocols. Adapt to your instrumentation and assay format.

Biological Roles

No target-specific biological claims are provided for this item. The following describes general properties of adenosine derivatives in biochemical research (literature-based, non-item-specific):

  • Adenosine scaffold recognition: Many proteins recognize adenosine motifs (e.g., kinases using ATP, nucleoside transporters, and enzymes of purine metabolism). Substitutions on the adenine ring, such as N6-alkyl groups, modulate binding interactions and selectivity.
  • Purinergic signaling context: Adenosine acts as an endogenous signaling molecule via cell-surface purine receptors; synthetic adenosine analogs are frequently used as research ligands to interrogate receptor pharmacology and downstream signaling in vitro. Specific receptor interactions for this item are not specified.
  • Enzymatic processing: Structural changes can reduce susceptibility to adenosine deaminase and other catabolic enzymes, extending stability in biological experiments; the extent for this item is not specified.
  • Physicochemical tuning: A 2-phenylethyl substituent generally increases hydrophobic character, potentially affecting membrane permeation and protein binding in cell-based assays (qualitative observation; extent is structure- and cell-line dependent).
  • Assay considerations: When used as a probe, include specificity controls (competition with native ligands, inactive analogs) and orthogonal readouts (binding vs function) to validate mechanism.

All statements above are general and should not be construed as item-specific performance. This product is designated For research use only.

Buffer Applications

This product is a small-molecule ligand candidate rather than a buffering reagent.

  • Item-specific: No buffering capacity, pKa set, or buffer-use specification is provided for P607137.
  • Practical guidance: Prepare in suitable solvents (commonly DMSO) and dilute into your chosen assay buffer (e.g., HEPES, PBS, Tris) based on assay requirements. Maintain final cosolvent at levels compatible with the biological system and instrumentation.

For buffer selection, refer to your assay’s pH stability window and target biology; the compound itself is not intended to define or maintain buffer pH.

Green Alternatives

Green chemistry for this item primarily concerns solvent choice during handling, stock preparation, and any synthetic workup involving analogs.

  • Item-specific: No solvent or process specifications are provided for P607137; recommendations below are general.

  • Greener dissolution and assay practices (general):

    • Prefer aqueous buffers whenever solubility permits. Use minimal DMSO (e.g., ≤0.5% v/v final) to reduce VOC load and potential cytotoxicity in cell-based assays.
    • Select ethanol or water–ethanol mixtures over DMF/NMP where feasible; these are generally more benign and easier to dispose of.
    • Micro-scale operations: Conduct screening and stock preparation at the smallest practical scale to minimize solvent use and waste.
  • Greener synthesis context (for related analog synthesis; literature-based):

    • Employ enzymatic and biocatalytic glycosylations or late-stage modifications when feasible to reduce protecting group and solvent-intensive steps typical of nucleoside chemistry.
    • Use water or water-lean solvent systems (e.g., 2-MeTHF) for coupling steps when compatible with nucleoside stability.
  • Tradeoffs:

    • Highly polar substrates often require aprotic polar solvents (DMSO/DMF) for adequate solubility; while not the greenest, judicious use at low volumes can be acceptable.
    • Ethanol is greener but may not dissolve more hydrophobic N6-arylalkyl derivatives effectively; limited cosolvent fractions may be necessary.

Comparison (general):

  • DMSO: excellent solubilizer; high boiling point; not volatile, but disposal considerations apply.
  • Ethanol/water: greener, safer; may have limited solubility for hydrophobic analogs.
  • DMF/NMP: strong solvents but with higher EHS concerns; avoid when alternatives suffice.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation specification is provided for this catalog item, and it is designated For research use only.

  • Item-specific: Not specified for this item; refer to CoA/Spec Sheet.

  • General research/manufacturing context (non-item-specific):

    • Small-molecule adenosine analogs are often utilized in discovery settings as reference standards, screening hits, or intermediates for medicinal chemistry optimization. They may be profiled in pre-formulation studies to assess solubility, stability, and compatibility with common vehicles; such activities remain strictly non-clinical.
    • For analytical development, adenosine-like compounds can serve as system suitability or retention-time markers in nucleoside LC methods when appropriately validated.

No therapeutic or clinical claims are made or implied for P607137.

Physical Properties

Item-specific measured properties are not provided for this catalog entry.

  • Item-specific (from Product Data):

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Other specifications (mp, bp, density, refractive index, UV cutoff, water/peroxide/metal limits): Not specified for this item; refer to CoA/Spec Sheet.
  • General/literature expectations for adenosine derivatives (non-item-specific):

    • Physical state: typically solid powders (often off-white to white) for nucleoside analogs.
    • Melting behavior: nucleosides and their N6-alkylated analogs often decompose or melt >150 °C; exact mp is highly structure-dependent.
    • Solubility: generally polar; frequently soluble in DMSO and DMF; aqueous solubility varies with substitution and salt form. Free bases may require co-solvents or pH adjustment.
    • Partitioning: N6-arylalkyl substitution tends to increase lipophilicity relative to adenosine; logP/logD values are highly substitution-dependent and not provided for this item.
    • Spectroscopy: purine chromophore absorbs in the UV (ca. 260–270 nm for adenosine core); substituents can shift intensity/position slightly (literature, not item-specific).

Please consult the CoA/Spec Sheet for definitive, lot-specific physical data pertinent to P607137.

Quality and Grades
  • Item-specific (from Product Data):

    • Grade/Purity: Moligand™ (small-molecule and compound library). Purity percentage and detailed analytical specs: Not specified for this item; refer to CoA/Spec Sheet.
  • What Moligand™ typically implies (general description of the grade):

    • Intended for discovery and screening workflows (e.g., binding assays, phenotypic screens, chemogenomic panels) where structural diversity and receptor/target engagement are of interest.
    • Practical attributes generally targeted in screening libraries: confirmed identity (by MS/NMR), research-use-only status, and compatibility with DMSO stock preparation. Exact QC elements are library- and item-dependent and should be verified on the CoA.
  • Analytical considerations (general, not item-specific):

    • Identity confirmation: 1H NMR/LC–MS are customary for small-molecule library items; high-resolution MS and purity by HPLC/UPLC may also be provided on request or via CoA.
    • UV profile: purine chromophores absorb in the 250–280 nm region; low-baseline absorbance and a single dominant peak in LC traces facilitate use in optical assays. Any UV cutoff or low-UV spec is Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/additives:

    • None are stated in Product Data. If stabilizers, salt forms, or counterions are critical to your application, confirm on the CoA/Spec Sheet prior to use.

Always consult the CoA/Spec Sheet for lot-specific purity, residual solvent profile, and analytical data for P607137.

Reaction and Applications
  • Item-specific application note (from Product Data):

    • Category Path: Small molecules and compound libraries (Moligand™). Manufacturer Applications: Not specified in the listing beyond inclusion in a screening library; use and expand based on general ligand-screening practices.
  • General research applications for adenosine-analogue ligands (non-item-specific):

    • Molecular probe/ligand screening: Evaluate binding and functional modulation in purine-related recognition systems (e.g., nucleoside-binding proteins, enzymes that utilize/recognize adenosine scaffolds). Suitable for primary/secondary assays, counterscreens, and SAR exploration.
    • Chemical biology: Tool compound in pathway deconvolution where adenosine-like motifs engage purine-interacting proteins; supports chemoproteomics pull-downs when derivatized with handles (biotin/alkyne), if permitted by structure.
    • Assay development: Reference ligand in assay validation (positive/negative control) once activity is established in-house; supports determination of Z′ factors and dynamic range.
    • Materials/recognition: Study of supramolecular systems recognizing purine nucleosides (H-bonding arrays, host–guest chemistry) to probe selectivity enhancements imparted by hydrophobic 2-phenylethyl substitution.
  • Practical considerations:

    • Ensure accurate mass and purity prior to biological readouts (LC–MS/HPLC check).
    • Prepare concentrated DMSO stocks; limit final DMSO in biological assays (commonly ≤0.5–1% v/v).
    • Include orthogonal counterscreens to distinguish purine-scaffold engagement from assay interference (PAINS filters, redox/aggregation controls). Add mild non-ionic detergent (e.g., 0.01% Tween-20) to mitigate colloidal aggregation if relevant.

All uses are for research only; no medical or clinical use is intended.

Reaction Conditions

No synthetic or processing conditions are specified for this catalog item. The following are general, literature-based conditions for preparing N6-alkylated adenosine analogs and related derivatives (non-item-specific):

  • N6-alkylation (SN2 on protected adenosine):

    • Substrate: 6-aminopurine riboside with 2′,3′-protected ribose (e.g., TBDMS or acetyl groups).
    • Electrophile: 2-phenethyl bromide or mesylate.
    • Base/solvent: K2CO3, Cs2CO3, or DIPEA in DMF/DMSO; 25–60 °C; 4–24 h.
    • Workup: Aqueous quench, extraction, deprotection, RP-HPLC purification. Yields vary widely (30–75%) depending on protection and sterics (literature ranges).
  • Buchwald–Hartwig amination (from 6-chloropurine riboside):

    • Catalyst: Pd2(dba)3 or Pd(OAc)2; ligands such as BINAP, XPhos.
    • Amine: 2-phenethylamine; base: NaOtBu or Cs2CO3; solvent: toluene/dioxane/DMF.
    • Temperature: 80–110 °C; time: 6–24 h. Typical isolated yields 40–80% (literature-dependent).
  • Reductive amination (adenine derivatives):

    • Carbonyl partner: 2-phenylacetaldehyde.
    • Reductant: NaBH3CN or NaBH(OAc)3 in MeOH/AcOH; 0–25 °C.
  • Analytical monitoring:

    • LC–MS with water/acetonitrile + 0.1% formic acid; UV detection near 260 nm.

These conditions are general guidance only and may not reflect the exact structure or optimal synthesis of P607137. Always consult primary literature and optimize experimentally.

Safety and Handling

Safety information specific to this item is not provided in the Product Data; defer to the SDS for authoritative guidance.

  • Item-specific (from Product Data):

    • GHS Classification: Not specified for this item; refer to SDS.
    • Signal Word: Not specified for this item; refer to SDS.
    • H-Statements: Not specified for this item; refer to SDS.
    • Pictograms: Not specified for this item; refer to SDS.
    • Storage Conditions: Room temperature.
  • General laboratory handling (non-item-specific):

    • Use appropriate PPE: lab coat, safety glasses, and suitable gloves (e.g., nitrile). Handle powders in a fume hood to minimize inhalation of dust.
    • Avoid contact with skin and eyes; prevent inhalation of dust/aerosols. Wash thoroughly after handling.
    • Incompatibilities: strong oxidizers and strong acids/bases may degrade nucleoside derivatives; avoid prolonged exposure to moisture and light if stability is unknown.
    • First aid (overview; consult SDS/medical professional):
      • Inhalation: move to fresh air; seek medical advice if symptoms occur.
      • Skin/eye contact: rinse with water for several minutes; remove contaminated clothing; seek medical advice if irritation persists.
      • Ingestion: rinse mouth; do not induce vomiting unless directed; seek medical attention.
  • Spill & disposal (general):

    • Contain solids with inert absorbent; avoid dust formation. Dispose of in accordance with institutional and local regulations.

For definitive hazard classification and exposure limits, consult the product SDS for P607137.

Solvent Selection
  • Item-specific (from Product Data):

    • No explicit solvent recommendations provided; Storage Conditions: Room temperature.
  • General guidance for adenosine derivatives and N6-arylalkyl analogs (literature-based):

    • Preferred stock solvent: DMSO is typically effective (e.g., 10–50 mM stocks) due to its ability to dissolve moderately lipophilic nucleoside derivatives while remaining miscible with aqueous assay buffers.
    • Alternative polar aprotic solvents: DMF, NMP can increase solubility for very hydrophobic substitutions; assess compatibility with your assay.
    • Aqueous media: Direct dissolution in water or buffer may be limited; incremental DMSO cosolvent (0.1–1% v/v in assays) often enables clear solutions. Adjust pH only if the compound bears ionizable groups—confirm structure on CoA.
    • Alcohols: Methanol or ethanol can assist in preparing intermediate concentrates prior to aqueous dilution; verify assay tolerance.
  • Polarity/miscibility context (general):

    • Adenosine core is polar; 2-phenylethyl substitution increases hydrophobicity, so the balance often favors polar aprotic solvents for initial dissolution, followed by buffered dilution.
  • Practical tips:

    • Warm gently (≤40 °C) and sonicate to assist dissolution; filter through 0.22 μm if particulate persists.
    • Minimize freeze–thaw of DMSO stocks by aliquoting.

For definitive solubility and solvent compatibility of P607137, consult the CoA/Spec Sheet or perform a micro-solubility screen under your assay conditions.

Storage and Reconstitution
  • Item-specific (from Product Data):

    • Storage Conditions (solid): Room temperature.
    • Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Reconstitution and handling (general guidance for small molecules; not item-specific):

    • Reconstitution solvent: Anhydrous DMSO is commonly used to prepare concentrated stocks (e.g., 10–50 mM). If aqueous use is required, dilute DMSO stocks into buffer with gentle mixing to avoid precipitation.
    • Filtration: If particulate remains, sterile-filter through a 0.22 μm PTFE or PVDF filter when sterility is necessary for cell-based assays.
    • Aliquoting: Prepare single-use aliquots to minimize freeze–thaw and moisture exposure.
    • Storage of solutions: DMSO stocks are often stored at −20 °C to extend shelf life; protect from light if the compound is photosensitive. Verify stability for your specific application.
  • Stability notes:

    • Avoid prolonged exposure to strong acids/bases and oxidants; moisture can impact some nucleoside derivatives. If long-term storage is planned, consider desiccation and light protection.

Always defer to the CoA/Spec Sheet and SDS for lot-specific stability, reconstitution recommendations, and safety notes for P607137.

Structure and Identity

Concise description: This item is listed as a 2-phenylethyl–adenosine derivative within a small-molecule ligand library (Moligand™).

  • Item-specific (from Product Data):

    • SKU: P607137
    • Product Name: 2-phenylethylyl-adenosine derivative
    • CAS: P607137 (catalog placeholder)
    • CID: 44598833 (catalog reference)
    • InChIKey: 272161 (catalog placeholder, not a standard InChIKey format)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • Grade/Purity: Moligand™
  • General structural features (literature, non-item-specific):

    • Adenosine derivatives comprise a purine base (adenine) N-linked to a ribofuranose sugar.
    • A “2-phenylethyl” substituent in adenosine chemistry commonly appears at the N6-position of the adenine ring (N6-(2-phenylethyl)adenosine is a known scaffold), though the exact substitution pattern for this catalog item is not specified.
    • Functional groups typically present: heteroaromatic purine ring (two fused rings with multiple nitrogens), ribose polyol (multiple alcohols), and an exocyclic amine at C6 of adenine (subject to substitution in N6-derivatives).
  • 2D structure (verbal, literature archetype):

    • Fused imidazole–pyrimidine (adenine) attached via N9 to a β-D-ribofuranose bearing hydroxyls at C2', C3', and C5' (often as free OH or protected). A 2-phenylethyl group, when present at N6, extends as –CH2–CH2–Ph from the exocyclic amino site on C6 of adenine. Exact isomerism/substitution for this item is not specified.
Synthetic Utility

While this item is offered as a finished small-molecule library member, adenosine derivatives as a class provide versatile synthetic handles (literature-based, not item-specific):

  • Functional group landscape:

    • Purine ring: electrophilic aromatic substitution at C8 (limited), N-alkylation/acylation at N6 (exocyclic amine), and cross-coupling from suitably halogenated purines.
    • Ribose: hydroxyls at 2′, 3′, and 5′ allow protection/deprotection strategies (e.g., TBDMS, TBDPS, acetyl, benzoyl) and selective derivatization.
  • Access to N6-(2-phenylethyl) motifs (general routes):

    • Reductive amination of 6-aminopurine derivatives with 2-phenylacetaldehyde followed by glycosylation, or vice versa.
    • N6-alkylation via activated 2-phenylethyl electrophiles (e.g., bromide/mesylate) under SN2 conditions on suitably protected adenosine or adenine, often with base (e.g., DIPEA, K2CO3) in polar aprotic solvents.
    • Buchwald–Hartwig amination on 6-chloropurine riboside with 2-phenethylamine using Pd catalysts and appropriate ligands.
  • Downstream elaboration:

    • Introduction of reporter handles (alkynes/azides) on the phenethyl ring for click-chemistry probes.
    • Phosphate and phosphoramidate prodrug motifs at 5′-OH to modulate uptake (ProTide-like strategies) in research synthesis.
  • Purification/analysis:

    • Reverse-phase preparative HPLC is common; monitor by UV at ~260 nm (adenosine chromophore). Confirm identity by HRMS and 1H/13C NMR.

The specific connectivity and protecting groups for P607137 are not disclosed; consult the CoA/Spec Sheet for definitive structural details.

Target Specificity

Target/receptor specificity, binding constants, and bioactivity data are not provided in the Product Data for P607137.

  • Item-specific: Not specified for this item; refer to CoA/Spec Sheet or internal screening data.

  • General note (non-item-specific):

    • Adenosine analogs can interact with a variety of purine-recognizing proteins. Any particular target profile for this compound must be established empirically under your assay conditions.

No claims of target engagement or potency are made for this product.

Foire aux questions

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is P607137. InChIKey PAFSPMXSTBOTSN-KSVNGYGVSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Besoin d'aide pour choisir la qualité ?

Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.

Voir le guide des qualités Moligand™ →

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.